About GEMMA BIOTHERAPEUTICS INC
Advancing gene therapy research and delivering life-changing therapeutics to patients around the world
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2024
- Company type
- Privately Held
- Company profile name
- GEMMA Biotherapeutics
GEMMABio, a new therapeutics company, will serve as the research and innovation arm to speed the research of and global access to life-changing advanced therapies for those living with rare diseases.
Alongside Franklin Biolabs, GEMMABio will advance gene therapy research and deliver therapeutics to patients around the world significantly faster.
Specialties
- Gene Therapy
- Rare Disease
- Quality Assurance
- GXP operations
- Regulatory affairs
- Clinical development
- Discovery research
- Translational research
- Vector research
- Biomedical research
- Orphan disease
- Genetic disease
- Genetic medicine
- AAV vectors
- Bioinformatics
- Capsid engineering
- and Genome editing
Company locations
3025 John F Kennedy Blvd, Suite 220, Philadelphia, Pennsylvania 19104, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biotechnology
- Therapeutics
On LinkedIn
- Followers
- 5,403
- People linked to this company
- 65
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
34,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.